Skip to main content

Experimental Ebola drugs approved by WHO

US company sends all available supplies of experimental drug ZMapp to Africa as other potential drugs move rapidly towards clinical trials.

Geneva (AFP) - The World Health Organization (WHO) has authorised the use of experimental drugs to fight Ebola as the death toll topped 1,000 and a Spanish priest became the first European to succumb to the outbreak. 

The declaration by the WHO, the UN's health agency, came Tuesday after a US company that makes anexperimental serum called ZMapp said it had sent all its available supplies to hard-hit west Africa. 
UN chief Ban Ki-moon announced plans to step up the global response to the outbreak, while urging governments to "avoid panic and fear" over an easily-preventable disease
The epidemic, the worst since Ebola was first discovered four decades ago, has killed 1,013 people since early this year. 
Cases have so far been limited to Guinea, Liberia and Sierra Leone, which account for the bulk of victims, and Nigeria with three deaths. 
Terror has gripped the impoverished west African countries ravaged by the disease, with harrowing tales emerging of people being shunned by their villages as the virus fells those around them. 
When AFP visited the Liberian village of Ballajah, some 150 kilometres from the capital Monrovia, 12-year-old Fatu Sherrif had been locked away with her mother's body without food and water for a week.
 

Her cries went unanswered as panicked residents fled the village when both her parents fell sick. 

Fatu later died and her brother Barnie, 15, despite testing negative for Ebola, was left alone and hungry in anabandoned house. 

"Nobody wants to come near me and they know -- people told them that I don't have Ebola," he told AFP.

- Promising vaccines -

Elderly Spanish priest Miguel Pajares, who became infected while helping patients in Liberia, died in a Madrid hospital on Tuesday, five days after being evacuated. 

He had been treated with ZMapp, which failed to save him but has shown positive effects on two US aid workers also infected in Liberia.... 

There is currently no available cure or vaccine for Ebola, which the WHO has declared a global public healthemergency, and the use of experimental drugs has stoked a fierce ethical debate

Despite promising results for the ZMapp treatment, made by private US company Mapp Biopharmaceutical, it had only been tested previously on monkeys. 

ZMapp is also in very short supply and the company said it had sent all available doses to west Africa free of charge, after an outcry over its use on foreign aid workers. The WHO was told three doses were sent to Liberia. 

While the ZMapp stock has been exhausted for now, there are other "potential therapies and vaccines... consideredvery serious alternatives" and possible vaccines are moving rapidly towards clinical trials

Plenty of drugs have been developed "to a point", but companies have not footed the bill for expensive clinical trials as the virus was "typically a disease of poor people in poor countries where there is no market". 

Drastic containment measures have caused transport chaos, price hikes and food shortages, and are stoking fears that people could die of hunger. 

Numerous countries around the globe have imposed emergency measures, including flight bans and improved health screenings

Sierra Leone President Ernest Bai Koroma meanwhile expressed his "utter dismay" at the "slow pace" of theinternational community in responding to the outbreak

Comments

Popular posts from this blog

The Rich Kids of Russia: Instagram mocks the children of oligarchs photographed posing beside luxury golden cars, mansions and private jets

An anonymous Instagram account revealing the lifestyles of the rich children of Russian oligarchs has become an internet sensation. The biography of the anonymous profile says it is dedicated to documenting the lives of the kids from Russia growing up in luxury.  The account specializes in collecting photos of rich Russian kids that they post online themselves, with everything from luxury cars through to selfies with expensive cars, boats or famous people.

$2million raised by Spark Internet Group

Jason Njoku, Bastian Gotter and Mary Remmy-Njoku launched Spark, the Lagos-based Internet Group that invests in Nigerian start-ups, a few months back. (If you missed it, read it HERE). They launched with a $1m investment fund and have just announced that due to huge interest in their company, they have secured another $2million from a pool of 17 international high net individual investors, based on a $10m valuation for the three month old company. It seems that the world now firmly has its eyes on Nigeria for exciting Internet companies to invest in!

Spark companies employ 130 people across the nine launched companies in Lagos, three of which have already secured second-round seed investments totaling an additional $700k from Njoku and Gotter. Continue...

Spark’s goal is to revolutionize Nigeria’s angel investment eco-system, focusing on the country’s Internet startup scene.   In an official press release, Jason Njoku of iROKOtv fame says: “Every Spark company we have invested in alread…

THE MAN PETER MBAH

Peter Mbah was born on the 17th, March 1972
He started his primary education in 1978. He attended the Army Children School, Bori Camp, Port Harcourt where he obtained his 1st School Leaving Certificate in 1984. In the same year, he proceeded to Owode High School, Owode Egba, Ogun State and in 1990, he graduated with a Senior Secondary Certificate in Education (SSCE) (O’Levels).
An adventurous Mbah obtained a Certificate in German as Foreign Language from the VolkHoch Schule, Recklinghausen, Germany in 1992. Between 1997 and year 2000, he attended the University of East London, United Kingdom where he graduated as a lawyer (.L.L.B (Hons)) with a Second Class Upper Division. While at the School, Mbah was an outstanding President of the Student Law Society (1998-1999). During his tenure, the association won the Students Union’s prize and certificate of achievement for the “Most Productive Society of the Year”.